Rare diseases
Investigational molecules
Locations
Back to Belgium4 clinical trials in Steenokkerzeel, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumBelgiumBelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on relapsing multiple sclerosis, evaluating the effectiveness of new therapeutic compounds compared to established treatments.
These studies aim to advance treatment options for patients experiencing MS relapses.
Specialized research examining nonrelapsing secondary progressive multiple sclerosis, with emphasis on disability progression prevention.
Current trials are exploring innovative treatments to slow disease advancement.
Groundbreaking studies investigating brain remyelination and neurodegeneration in progressive multiple sclerosis using established medications in new applications.
Research focuses on long-term treatment outcomes over 96-week periods.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
